So, although 150m were listed as expiring on 30 November, only...

So, although 150m were listed as expiring on 30 November, only 123m were actually exercised ( @ 0.003) - so slightly less dilution and 27m less being flogged post exercise.

that is the last of the 3 tranches of oppies expiring in 2021, per below table.

	Date	no. issued	Ex Price	expiry date	status	No	$
1	Jul-21	12,500,000	0.045	15/07/2021	expired	12,500,000	562,500
2		846,666,665	0.003	30/09/2021	exercised	846,666,665	2,540,000
3	Dec-21	150,000,000	0.003	30/11/2021	123.33m exercised	123,333,334	370,000

So, while netting $3.5m of cash to fund the company, it has generated a huge amount of sales as funders have realised their profit on a short term basis and has distorted AXP's underlying value and performance.

The above is circa 1bn shares and that is a huge volume relative to the number generally traded. This has doubtless been the major contributor to the recent price falls. Professional funders have no mandate to hold after paying to exercise and so would have been selling in droves since.

the good news is that they are now all exercised and the next exercise date is 30 April 2023, so will be quiet for a while. There may still be some short term pain, with options being exercised at .3c and selling at even .6c represents a 100% profit for the brokers / holders who exercise.

all leading to a great 2022 for the company and long term holders.

Wazz